improving target identification in patients with advanced nsclc via up-front ctdna
Published 2 years ago • 97 plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
2:00
ctdna-ngs versus routine tissue testing in patients with advanced nsclc
-
0:53
"how can ctdna improve detection and monitoring of my specific cancer?”
-
1:07
ctdna mrd detection in patients with nsclc
-
1:22
the identification of actionable mutations in lung cancer via ctdna
-
1:14
detecting ctdna in patients with nsclc receiving adagrasib
-
1:49
ctdna ngs for treatment decision-making in nsclc
-
2:40
analysis of patients with no baseline ctdna in the intrigue trial
-
3:06
the application of liquid biopsy ctdna analysis in nsclc
-
52:46
"circulating tumour dna: an increasingly powerful diagnostic tool for oncology" - nitzan rosenfeld
-
2:02
applications of ctdna in lung cancer: informing treatment approaches, mrd and screening
-
6:55
the prognostic value of ctdna in nsclc treated with neoadjuvant chemoimmunotherapy
-
12:01
debate: is circulating tumor dna ready to guide adjuvant therapy in colon cancer? - yes
-
52:48
improving cancer diagnosis and treatment with ctdna
-
3:30
ctdna as an mrd biomarker for nsclc
-
6:34
plx8394 in patients with advanced cancer: activity, safety and ctdna
-
1:33
climb360: ctdna-based molecular screening
-
4:25
technical considerations for ctdna testing in nsclc
-
2:08
managing lung cancer in ild patients and implementing ctdna testing in the nhs
-
5:05
managing patients with crc using ctdna